In March 2015, the initial investors for the Dementia Discovery Fund (DDF) were announced at the World Health Organization Global Dementia Conference, where Health Ministers from over 60 countries attended the Conference to meet leaders from other multinational organizations, NGOs, philanthropic organizations and technical experts.

We celebrated the launch of the DDF on 21 October, 2015, which included the first close of capital and the appointment of SV Life Sciences as the fund manager. This has been a fantastic effort by everyone involved from Lilly, Takeda, Biogen, Pfizer, GSK Johnson & Johnson, and Alzheimer’s’ Research UK to support the creation of the DDF alongside the UK Department of Health. This is truly a one of a kind public-partnership targeting a disease area that we all are focused on. Further details can be found in the ARUK press release.